550th Edition, March 21, 2023

March 21, 2023

SVB Collapse Appears to Only Have Minor Ripples for BioHealth Capital Region and Greater Philly’s Biotech Scene – BioBuzz

The collapse of Silicon Valley Bank (SVB) on Friday, March 10, sent shockwaves through the tech and biotech world. But it does not appear to have had a major effect on the BioHealth Capital Region and the Philadelphia region’s life sciences industry, at least not so far.On about March 8, SVB, a major supporter of tech, biotech and venture capital funds, indicated it was facing a cashflow problem. Initially, it attempted to raise money by selling shares. Then it attempted to sell itself. Investors were alarmed by these efforts and began pulling their funds from the bank, causing a run on the bank, leading to shares plunging on Thursday, March 9. On Friday, March 10, regulators shut down the bank.Image: https://biobuzz.io/

RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing

FREDERICK, Md., March 13, 2023 /PRNewswire-PRWeb/ — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, today announced that it has selected Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, as a collaboration partner to advance scalable exosome bioprocessing.RoosterBio’s goal, in collaboration with Repligen, is to deliver solutions for manufacturing of exosomes using scalable and low shear technologies that enable cost-effective commercialization of these advanced therapies.

Intro to Quantum for Life Sciences Tickets, Tue, Mar 28, 2023 at 12:00 PM | Eventbrite

Join us for a lunch and learn to hear how new technologies in quantum computing will be utilized to power scientific research and the life science companies already taking advantage. Shahar Keinan, CEO, and Maurice Benson, Lead Software Engineer at POLARISqb, will give a presentation on how the innovations in the quantum computing industry will directly impact the future of drug design, clinical research, and precision medicine. POLARISqb has created one of the first platforms for the life sciences industry that can cut the drug discovery research process timeline from its traditional time of 5 years down to 4 months. Shahar and Maurice will also discuss how quantum computers are beginning to be made ready for commercial use and all of the recent case studies on their performance.

Unlocking ARPA-H Funding Opportunities: How BioHealth Innovation’s Experienced Team is Guiding Life Science Companies to Success

Advanced Research Projects Agency for Health (ARPA-H) has recently opened its first Agency-wide Open Broad Agency Announcement (BAA), which seeks funding proposals for research to improve health outcomes across patient populations, communities, diseases, and health conditions. The BAA calls for proposals that outline breakthrough research and technological advancements, investigate unconventional approaches, and challenge accepted assumptions to enable leaps forward in science, technology, systems, or related capabilities. ARPA-H also encourages concepts that advance the objectives of President Biden’s Cancer Moonshot initiative, as well as more disease-agnostic approaches.

After the SVB crisis, what’s next for venture capital?

The tragic and shocking demise of SVB and bailout of its depositors is a watershed, “Too Big to Fail” event for Silicon Valley that will reverberate for years to come, if not longer, bringing significant new challenges to the industry in both the short and long term.For the small but critically important world of startups and venture capital, things have gone from bad to worse. After a year of upheaval—plummeting stock valuations, dormant M&A and IPO markets, and massive layoffs—the tech industry now bears the indignity of losing a cherished institution that nearly sparked a national financial panic.Image: Giorgio Trovato/Unsplash, Jesse Bowser/Unsplash

Save the date for the 9th Annual BioHealth Capital Region Forum on September 19th and 20th, 2023!

Save the date for the 9th Annual BioHealth Capital Region Forum on September 19th and 20th, 2023! Join us for two days of highlighting innovation and entrepreneurship as we bring together the best of our region and beyond to collaborate and shape the future of healthcare. Location and registration information coming soon.

EIR Feedback Day – April 19

This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@biohealthinnovation.orgThe requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!

BioTalk Podcast Welcomes Immunyx Pharma Co-Founder & CEO, Seth Salpeter

Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are changing the landscape of immune modulation in the battle against diseases with the JLABS/BARDA Blue Knight program on this episode of BioTalk with Rich Bendis.Also Available on popular podcast platforms like Apple https://apple.co/3LlbxIy, Google https://bit.ly/3l6O6ba, Spotify https://spoti.fi/405ln5B, Amazon Music https://amzn.to/3J58kde, TuneIn https://bit.ly/3JA8MBO, and even YouTube https://bit.ly/3LhYZS6.

About BioHealth Innovation

Contact

Connect